CStone Pharmaceuticals Initiates Two Pivotal Phase II Studies of the Anti-PD-L1 Monoclonal Antibody CS1001
SUZHOU, China, June 13, 2018 /…
The Art & Science of Wellness
SUZHOU, China, June 13, 2018 /…
HSINCHU and WUHAN, June 14, 20…
-The improvement in the air qu…
-Rapidly Aging Global Populati…
John Yoon Named Managing Direc…
BEIJING, June 5, 2018 /PRNewsw…
多语言WordPress ,采用WPML